Global Migraine Treatment Market Size study, by Types (Episodic, Migraine with Aura, Chronic and Others), by Treatment (Acute/Abortive Treatment, Preventive/Prophylactic Treatment, Non-Pharmacological Therapies and Devices), by Product Type (Prescription and Over the Counter), by End-User (Hospitals, Clinics, Homecare, Others) and Regional Forecasts 2022-2028
- BIZ4982848
- 200 Pages
- May 2022
- Pharmaceuticals
The key regions considered for the Global Migraine Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the global market in terms of revenue owing to the presence of established players and rising prevalence of migraine. Whereas, Asia Pacific is expected to grow with the highest growth rate in coming years, owing to research and development activities happening in the region coupled with rising healthcare expenditure.
Major market players included in this report are:
Pfizer Inc.
Eli Lilly and Company
Amgen Inc.
GlaxoSmithKline plc.
Novartis AG
Bayer AG
Allergan
Abbott
Allodynic Therapeutics, LLC
AOBiome
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Treatment offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Types:
Episodic
Migraine with Aura
Chronic
Others
By Treatment:
Acute/Abortive Treatment
Preventive/prophylactic Treatment
Non-Pharmacological Therapies and Devices
By Product Type:
Prescription
Over The Counter
By End-User:
Hospitals
Clinics
Homecare
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Migraine Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Migraine Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Migraine Treatment Market, by Types, 2020-2028 (USD Billion)
1.2.3. Migraine Treatment Market, by Treatment, 2020-2028 (USD Billion)
1.2.4. Migraine Treatment Market, by Product Type, 2020-2028 (USD Billion)
1.2.5. Migraine Treatment Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Migraine Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Migraine Treatment Market Dynamics
3.1. Migraine Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising awareness
3.1.1.2. Growing migraine prevalence
3.1.2. Market Challenges
3.1.2.1. Presence of alternative therapies
3.1.2.2. Limitations of current therapies
3.1.3. Market Opportunities
3.1.3.1. Approval for new treatment
3.1.3.2. Research and development activities
Chapter 4. Global Migraine Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Migraine Treatment Market, by Types
6.1. Market Snapshot
6.2. Global Migraine Treatment Market by Types, Performance - Potential Analysis
6.3. Global Migraine Treatment Market Estimates & Forecasts by Types, 2018-2028 (USD Billion)
6.4. Migraine Treatment Market, Sub Segment Analysis
6.4.1. Episodic
6.4.2. Migraine with Aura
6.4.3. Chronic
6.4.4. Others
Chapter 7. Global Migraine Treatment Market, by Treatment
7.1. Market Snapshot
7.2. Global Migraine Treatment Market by Treatment, Performance - Potential Analysis
7.3. Global Migraine Treatment Market Estimates & Forecasts by Treatment, 2018-2028 (USD Billion)
7.4. Migraine Treatment Market, Sub Segment Analysis
7.4.1. Acute/Abortive Treatment
7.4.2. Preventive/prophylactic Treatment
7.4.3. Non-Pharmacological Therapies and Devices
Chapter 8. Global Migraine Treatment Market, by Product Type
8.1. Market Snapshot
8.2. Global Migraine Treatment Market by Product Type, Performance - Potential Analysis
8.3. Global Migraine Treatment Market Estimates & Forecasts by Product Type, 2018-2028 (USD Billion)
8.4. Migraine Treatment Market, Sub Segment Analysis
8.4.1. Prescription
8.4.2. Over The Counter
Chapter 9. Global Migraine Treatment Market, by End-User
9.1. Market Snapshot
9.2. Global Migraine Treatment Market by End-User, Performance - Potential Analysis
9.3. Global Migraine Treatment Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
9.4. Migraine Treatment Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Homecare
9.4.4. Others
Chapter 10. Global Migraine Treatment Market, Regional Analysis
10.1. Migraine Treatment Market, Regional Market Snapshot
10.2. North America Migraine Treatment Market
10.2.1. U.S. Migraine Treatment Market
10.2.1.1. Types breakdown estimates & forecasts, 2018-2028
10.2.1.2. Treatment breakdown estimates & forecasts, 2018-2028
10.2.1.3. Product Type breakdown estimates & forecasts, 2018-2028
10.2.1.4. End-User breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Migraine Treatment Market
10.3. Europe Migraine Treatment Market Snapshot
10.3.1. U.K. Migraine Treatment Market
10.3.2. Germany Migraine Treatment Market
10.3.3. France Migraine Treatment Market
10.3.4. Spain Migraine Treatment Market
10.3.5. Italy Migraine Treatment Market
10.3.6. Rest of Europe Migraine Treatment Market
10.4. Asia-Pacific Migraine Treatment Market Snapshot
10.4.1. China Migraine Treatment Market
10.4.2. India Migraine Treatment Market
10.4.3. Japan Migraine Treatment Market
10.4.4. Australia Migraine Treatment Market
10.4.5. South Korea Migraine Treatment Market
10.4.6. Rest of Asia Pacific Migraine Treatment Market
10.5. Latin America Migraine Treatment Market Snapshot
10.5.1. Brazil Migraine Treatment Market
10.5.2. Mexico Migraine Treatment Market
10.6. Rest of The World Migraine Treatment Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Pfizer Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Treatment Summary
11.2.1.5. Recent Developments
11.2.2. Eli Lilly and Company
11.2.3. Amgen Inc.
11.2.4. GlaxoSmithKline plc.
11.2.5. Novartis AG
11.2.6. Bayer AG
11.2.7. Allergan
11.2.8. Abbott
11.2.9. Allodynic Therapeutics, LLC
11.2.10. AOBiome
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Migraine Treatment market, report scope
TABLE 2. Global Migraine Treatment market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Migraine Treatment market estimates & forecasts by Types 2018-2028 (USD Billion)
TABLE 4. Global Migraine Treatment market estimates & forecasts by Treatment 2018-2028 (USD Billion)
TABLE 5. Global Migraine Treatment market estimates & forecasts by Product Type 2018-2028 (USD Billion)
TABLE 6. Global Migraine Treatment market estimates & forecasts by End-User 2018-2028 (USD Billion)
TABLE 7. Global Migraine Treatment market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Migraine Treatment market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Migraine Treatment market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Migraine Treatment market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Migraine Treatment market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Migraine Treatment market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Migraine Treatment market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Migraine Treatment market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Migraine Treatment market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Migraine Treatment market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Migraine Treatment market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Migraine Treatment market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Migraine Treatment market
TABLE 57. List of primary sources, used in the study of global Migraine Treatment market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
